Two Cooperative Research Centre Projects (CRC-P) involving The University of Queensland have received funding under the Federal Government program, which provides support for industry-led research collaborations.
The first project involving UQ will be led by Brisbane biotechnology company Vaxxas and involves advancing the development and clinical testing of the first COVID-19 vaccine delivered using a needle-free skin patch.
